ArticleCancers2021

Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study.

Rianne D W Vaes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.